Global RNA Modified Pseudouridine Market Research Report 2024

Publication ID:

PB509240413

Publication Date:

September 2, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.
The global RNA Modified Pseudouridine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for RNA Modified Pseudouridine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Modified Pseudouridine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA Modified Pseudouridine in mRNA Vaccines is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA Modified Pseudouridine include YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Fine Biotech, Shanghai Hongene Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Modified Pseudouridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Modified Pseudouridine.
The RNA Modified Pseudouridine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Modified Pseudouridine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Modified Pseudouridine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori
Segment by Type
Solution
Powder
Segment by Application
mRNA Vaccines
Gene Expression and Therapy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Modified Pseudouridine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Modified Pseudouridine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Solution
1.2.3 Powder
1.3 Market by Application
1.3.1 Global RNA Modified Pseudouridine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 mRNA Vaccines
1.3.3 Gene Expression and Therapy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Modified Pseudouridine Market Perspective (2019-2030)
2.2 Global RNA Modified Pseudouridine Growth Trends by Region
2.2.1 Global RNA Modified Pseudouridine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNA Modified Pseudouridine Historic Market Size by Region (2019-2024)
2.2.3 RNA Modified Pseudouridine Forecasted Market Size by Region (2025-2030)
2.3 RNA Modified Pseudouridine Market Dynamics
2.3.1 RNA Modified Pseudouridine Industry Trends
2.3.2 RNA Modified Pseudouridine Market Drivers
2.3.3 RNA Modified Pseudouridine Market Challenges
2.3.4 RNA Modified Pseudouridine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Modified Pseudouridine Players by Revenue
3.1.1 Global Top RNA Modified Pseudouridine Players by Revenue (2019-2024)
3.1.2 Global RNA Modified Pseudouridine Revenue Market Share by Players (2019-2024)
3.2 Global RNA Modified Pseudouridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA Modified Pseudouridine Revenue
3.4 Global RNA Modified Pseudouridine Market Concentration Ratio
3.4.1 Global RNA Modified Pseudouridine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Modified Pseudouridine Revenue in 2023
3.5 Global Key Players of RNA Modified Pseudouridine Head office and Area Served
3.6 Global Key Players of RNA Modified Pseudouridine, Product and Application
3.7 Global Key Players of RNA Modified Pseudouridine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Modified Pseudouridine Breakdown Data by Type
4.1 Global RNA Modified Pseudouridine Historic Market Size by Type (2019-2024)
4.2 Global RNA Modified Pseudouridine Forecasted Market Size by Type (2025-2030)
5 RNA Modified Pseudouridine Breakdown Data by Application
5.1 Global RNA Modified Pseudouridine Historic Market Size by Application (2019-2024)
5.2 Global RNA Modified Pseudouridine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNA Modified Pseudouridine Market Size (2019-2030)
6.2 North America RNA Modified Pseudouridine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNA Modified Pseudouridine Market Size by Country (2019-2024)
6.4 North America RNA Modified Pseudouridine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Modified Pseudouridine Market Size (2019-2030)
7.2 Europe RNA Modified Pseudouridine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNA Modified Pseudouridine Market Size by Country (2019-2024)
7.4 Europe RNA Modified Pseudouridine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Modified Pseudouridine Market Size (2019-2030)
8.2 Asia-Pacific RNA Modified Pseudouridine Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNA Modified Pseudouridine Market Size by Region (2019-2024)
8.4 Asia-Pacific RNA Modified Pseudouridine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Modified Pseudouridine Market Size (2019-2030)
9.2 Latin America RNA Modified Pseudouridine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNA Modified Pseudouridine Market Size by Country (2019-2024)
9.4 Latin America RNA Modified Pseudouridine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Modified Pseudouridine Market Size (2019-2030)
10.2 Middle East & Africa RNA Modified Pseudouridine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNA Modified Pseudouridine Market Size by Country (2019-2024)
10.4 Middle East & Africa RNA Modified Pseudouridine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 YAMASA CORPORATION
11.1.1 YAMASA CORPORATION Company Details
11.1.2 YAMASA CORPORATION Business Overview
11.1.3 YAMASA CORPORATION RNA Modified Pseudouridine Introduction
11.1.4 YAMASA CORPORATION Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.1.5 YAMASA CORPORATION Recent Development
11.2 Biosynth Carbosynth
11.2.1 Biosynth Carbosynth Company Details
11.2.2 Biosynth Carbosynth Business Overview
11.2.3 Biosynth Carbosynth RNA Modified Pseudouridine Introduction
11.2.4 Biosynth Carbosynth Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.2.5 Biosynth Carbosynth Recent Development
11.3 TriLink BioTechnologies
11.3.1 TriLink BioTechnologies Company Details
11.3.2 TriLink BioTechnologies Business Overview
11.3.3 TriLink BioTechnologies RNA Modified Pseudouridine Introduction
11.3.4 TriLink BioTechnologies Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.3.5 TriLink BioTechnologies Recent Development
11.4 MP Biomedicals, Inc
11.4.1 MP Biomedicals, Inc Company Details
11.4.2 MP Biomedicals, Inc Business Overview
11.4.3 MP Biomedicals, Inc RNA Modified Pseudouridine Introduction
11.4.4 MP Biomedicals, Inc Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.4.5 MP Biomedicals, Inc Recent Development
11.5 Thermo Scientific Chemicals
11.5.1 Thermo Scientific Chemicals Company Details
11.5.2 Thermo Scientific Chemicals Business Overview
11.5.3 Thermo Scientific Chemicals RNA Modified Pseudouridine Introduction
11.5.4 Thermo Scientific Chemicals Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.5.5 Thermo Scientific Chemicals Recent Development
11.6 BOC Sciences
11.6.1 BOC Sciences Company Details
11.6.2 BOC Sciences Business Overview
11.6.3 BOC Sciences RNA Modified Pseudouridine Introduction
11.6.4 BOC Sciences Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.6.5 BOC Sciences Recent Development
11.7 Toronto Research Chemical
11.7.1 Toronto Research Chemical Company Details
11.7.2 Toronto Research Chemical Business Overview
11.7.3 Toronto Research Chemical RNA Modified Pseudouridine Introduction
11.7.4 Toronto Research Chemical Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.7.5 Toronto Research Chemical Recent Development
11.8 Wuhan Glycogene
11.8.1 Wuhan Glycogene Company Details
11.8.2 Wuhan Glycogene Business Overview
11.8.3 Wuhan Glycogene RNA Modified Pseudouridine Introduction
11.8.4 Wuhan Glycogene Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.8.5 Wuhan Glycogene Recent Development
11.9 Fine Biotech
11.9.1 Fine Biotech Company Details
11.9.2 Fine Biotech Business Overview
11.9.3 Fine Biotech RNA Modified Pseudouridine Introduction
11.9.4 Fine Biotech Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.9.5 Fine Biotech Recent Development
11.10 Shanghai Hongene Biotech
11.10.1 Shanghai Hongene Biotech Company Details
11.10.2 Shanghai Hongene Biotech Business Overview
11.10.3 Shanghai Hongene Biotech RNA Modified Pseudouridine Introduction
11.10.4 Shanghai Hongene Biotech Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.10.5 Shanghai Hongene Biotech Recent Development
11.11 Biori
11.11.1 Biori Company Details
11.11.2 Biori Business Overview
11.11.3 Biori RNA Modified Pseudouridine Introduction
11.11.4 Biori Revenue in RNA Modified Pseudouridine Business (2019-2024)
11.11.5 Biori Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂